Here's the lowdown from allergy doctors on how to get relief, from which medicines to use — and how to best use them — to ...

It was a first for cows last March when the U.S. Department of Agriculture announced the highly pathogenic avian flu virus ...

“But you shouldn’t use a decongestant nasal spray for more than 3 days in a row to avoid rebound congestion that can be difficult to treat.” Laura is Popular Science’s news ...

Researchers have created an H5N1 avian influenza, or bird flu, vaccine that can be administered as a nasal spray. The influenza virus vector-based nasal spray vaccine platform was first developed ...

They had given patients oral supplements of vitamin D to reduce nasal inflammation and reverse the loss of the sense of smell the inflammation often causes. "It helped zero of 28 people," she said.

“Definitely avoid decongestant sprays such as oxymetazoline ... “It’s much better to use a nasal steroid spray, but remember they need to be used consistently to work,” he said.

Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...

The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong (HKU) and the InnoHK Centre for Virology, Vaccinology and Therapeutics (CVVT) have pioneered an influenza virus ...

In a viral TikTok, Amber Guttilla reveals there is a wrong way to use nasal spray. Allergist Dr. Robert Sporter explains how to get it right for allergies.

For patients with seizure episodes reaching t1 (671 events of t1 SE in 97 patients), diazepam nasal spray provided timely control of SE episodes. Overall, safety was generally consistent with the ...

While not a nasal steroid, Kachru advises against using oxymetazoline (Afrin), a nasal spray decongestant. “Patients who use Afrin regularly end up having really, really severe rebound nasal ...

Milestone® Pharmaceuticals (NASDAQ:MIST) announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for its New Drug Application (NDA) for CARDAMYST™ ...